APO Research

APO RESEARCH · REPORT

Androgenetic Alopecia Treatment

Selected research

Market Structure

Global Androgenetic Alopecia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Androgenetic Alopecia Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Androgenetic Alopecia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Androgenetic Alopecia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Androgenetic Alopecia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Androgenetic Alopecia Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Androgenetic Alopecia Treatment include Sun Pharmaceuticals Industries Ltd, Merck & Co., Inc, Vita-Cos-Med Klett-Loch GmbH, Vitabiotics, Ranbaxy Laboratories Ltd., PureTech, Lexington International LLC, Johnson and Johnson Services, Inc and Histogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Androgenetic Alopecia Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Androgenetic Alopecia Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Androgenetic Alopecia Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Androgenetic Alopecia Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Androgenetic Alopecia Treatment Segment by Company

Sun Pharmaceuticals Industries Ltd

Merck & Co., Inc

Vita-Cos-Med Klett-Loch GmbH

Vitabiotics

Ranbaxy Laboratories Ltd.

PureTech

Lexington International LLC

Johnson and Johnson Services, Inc

Histogen Inc

HCell Inc

Follica, Inc

Dr. Reddy’s Laboratories

Daiichi-Sankyo Co., Ltd

Concert Pharmaceuticals Inc.

Cipla Limited

Aclaris Therapeutics, Inc

Androgenetic Alopecia Treatment Segment by Type

Topical Agents

5 AR Inhibitors

Others

Androgenetic Alopecia Treatment Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Androgenetic Alopecia Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgenetic Alopecia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgenetic Alopecia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgenetic Alopecia Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Androgenetic Alopecia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Androgenetic Alopecia Treatment industry.

Chapter 3: Detailed analysis of Androgenetic Alopecia Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgenetic Alopecia Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Androgenetic Alopecia Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Topical Agents Table 3. Key Players of 5 AR Inhibitors Table 4. Key Players of Others Table 4. Global Androgenetic Alopecia Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Retail Pharmacies Table 6. Key Players of Online Pharmacies Table 7. Key Players of Hospital Pharmacies Table 8. Global Androgenetic Alopecia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Androgenetic Alopecia Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Androgenetic Alopecia Treatment Market Share by Region (2021-2026) Table 11. Global Androgenetic Alopecia Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Androgenetic Alopecia Treatment Market Share by Region (2027-2032) Table 13. Androgenetic Alopecia Treatment Industry Trends Table 14. Androgenetic Alopecia Treatment Industry Drivers Table 15. Androgenetic Alopecia Treatment Industry Opportunities and Challenges Table 16. Androgenetic Alopecia Treatment Industry Restraints Table 17. Global Androgenetic Alopecia Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Androgenetic Alopecia Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Androgenetic Alopecia Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Androgenetic Alopecia Treatment Key Company Head Office and Area Served Table 21. Global Androgenetic Alopecia Treatment Company, Product Type & Application Table 22. Global Androgenetic Alopecia Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Androgenetic Alopecia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Androgenetic Alopecia Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Androgenetic Alopecia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Androgenetic Alopecia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Androgenetic Alopecia Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Androgenetic Alopecia Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Androgenetic Alopecia Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Androgenetic Alopecia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Androgenetic Alopecia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Androgenetic Alopecia Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Androgenetic Alopecia Treatment Revenue Market Share by Application (2027-2032) Table 35. Sun Pharmaceuticals Industries Ltd Company Information Table 36. Sun Pharmaceuticals Industries Ltd Business Overview Table 37. Sun Pharmaceuticals Industries Ltd Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sun Pharmaceuticals Industries Ltd Androgenetic Alopecia Treatment Product Portfolio Table 39. Sun Pharmaceuticals Industries Ltd Recent Development Table 40. Merck & Co., Inc Company Information Table 41. Merck & Co., Inc Business Overview Table 42. Merck & Co., Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck & Co., Inc Androgenetic Alopecia Treatment Product Portfolio Table 44. Merck & Co., Inc Recent Development Table 45. Vita-Cos-Med Klett-Loch GmbH Company Information Table 46. Vita-Cos-Med Klett-Loch GmbH Business Overview Table 47. Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Product Portfolio Table 49. Vita-Cos-Med Klett-Loch GmbH Recent Development Table 50. Vitabiotics Company Information Table 51. Vitabiotics Business Overview Table 52. Vitabiotics Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Vitabiotics Androgenetic Alopecia Treatment Product Portfolio Table 54. Vitabiotics Recent Development Table 55. Ranbaxy Laboratories Ltd. Company Information Table 56. Ranbaxy Laboratories Ltd. Business Overview Table 57. Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Product Portfolio Table 59. Ranbaxy Laboratories Ltd. Recent Development Table 60. PureTech Company Information Table 61. PureTech Business Overview Table 62. PureTech Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. PureTech Androgenetic Alopecia Treatment Product Portfolio Table 64. PureTech Recent Development Table 65. Lexington International LLC Company Information Table 66. Lexington International LLC Business Overview Table 67. Lexington International LLC Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lexington International LLC Androgenetic Alopecia Treatment Product Portfolio Table 69. Lexington International LLC Recent Development Table 70. Johnson and Johnson Services, Inc Company Information Table 71. Johnson and Johnson Services, Inc Business Overview Table 72. Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Product Portfolio Table 74. Johnson and Johnson Services, Inc Recent Development Table 75. Histogen Inc Company Information Table 76. Histogen Inc Business Overview Table 77. Histogen Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Histogen Inc Androgenetic Alopecia Treatment Product Portfolio Table 79. Histogen Inc Recent Development Table 80. HCell Inc Company Information Table 81. HCell Inc Business Overview Table 82. HCell Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. HCell Inc Androgenetic Alopecia Treatment Product Portfolio Table 84. HCell Inc Recent Development Table 85. Follica, Inc Company Information Table 86. Follica, Inc Business Overview Table 87. Follica, Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Follica, Inc Androgenetic Alopecia Treatment Product Portfolio Table 89. Follica, Inc Recent Development Table 90. Dr. Reddy’s Laboratories Company Information Table 91. Dr. Reddy’s Laboratories Business Overview Table 92. Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Product Portfolio Table 94. Dr. Reddy’s Laboratories Recent Development Table 95. Daiichi-Sankyo Co., Ltd Company Information Table 96. Daiichi-Sankyo Co., Ltd Business Overview Table 97. Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Product Portfolio Table 99. Daiichi-Sankyo Co., Ltd Recent Development Table 100. Concert Pharmaceuticals Inc. Company Information Table 101. Concert Pharmaceuticals Inc. Business Overview Table 102. Concert Pharmaceuticals Inc. Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Concert Pharmaceuticals Inc. Androgenetic Alopecia Treatment Product Portfolio Table 104. Concert Pharmaceuticals Inc. Recent Development Table 105. Cipla Limited Company Information Table 106. Cipla Limited Business Overview Table 107. Cipla Limited Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Cipla Limited Androgenetic Alopecia Treatment Product Portfolio Table 109. Cipla Limited Recent Development Table 110. Aclaris Therapeutics, Inc Company Information Table 111. Aclaris Therapeutics, Inc Business Overview Table 112. Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Product Portfolio Table 114. Aclaris Therapeutics, Inc Recent Development Table 115. North America Androgenetic Alopecia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Androgenetic Alopecia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Androgenetic Alopecia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Androgenetic Alopecia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Androgenetic Alopecia Treatment Market Size by Country (2021-2026) Table 121. North America Androgenetic Alopecia Treatment Market Size by Country (2027-2032) Table 122. Europe Androgenetic Alopecia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Androgenetic Alopecia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Androgenetic Alopecia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Androgenetic Alopecia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Androgenetic Alopecia Treatment Market Size by Country (2021-2026) Table 128. Europe Androgenetic Alopecia Treatment Market Size by Country (2027-2032) Table 129. China Androgenetic Alopecia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 130. China Androgenetic Alopecia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 131. China Androgenetic Alopecia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 132. China Androgenetic Alopecia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Androgenetic Alopecia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Androgenetic Alopecia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Androgenetic Alopecia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Androgenetic Alopecia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Androgenetic Alopecia Treatment Market Size by Country (2021-2026) Table 139. Asia Androgenetic Alopecia Treatment Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Androgenetic Alopecia Treatment Product Image Figure 2. Global Androgenetic Alopecia Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Androgenetic Alopecia Treatment Market Share by Type: 2025 VS 2032 Figure 4. Topical Agents Image Figure 5. 5 AR Inhibitors Image Figure 6. Others Image Figure 7. Global Androgenetic Alopecia Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Androgenetic Alopecia Treatment Market Share by Application: 2025 VS 2032 Figure 9. Retail Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Global Androgenetic Alopecia Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Androgenetic Alopecia Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Androgenetic Alopecia Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Androgenetic Alopecia Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Androgenetic Alopecia Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Androgenetic Alopecia Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Androgenetic Alopecia Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Androgenetic Alopecia Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Androgenetic Alopecia Treatment Market Share by Type (2021-2032) Figure 25. North America Androgenetic Alopecia Treatment Market Share by Application (2021-2032) Figure 26. North America Androgenetic Alopecia Treatment Market Share by Country (2021-2032) Figure 27. United States Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Androgenetic Alopecia Treatment Market Share by Type (2021-2032) Figure 32. Europe Androgenetic Alopecia Treatment Market Share by Application (2021-2032) Figure 33. Europe Androgenetic Alopecia Treatment Market Share by Country (2021-2032) Figure 34. Germany Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Androgenetic Alopecia Treatment Market Share by Type (2021-2032) Figure 42. China Androgenetic Alopecia Treatment Market Share by Application (2021-2032) Figure 43. Asia Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Androgenetic Alopecia Treatment Market Share by Type (2021-2032) Figure 45. Asia Androgenetic Alopecia Treatment Market Share by Application (2021-2032) Figure 46. Asia Androgenetic Alopecia Treatment Market Share by Country (2021-2032) Figure 47. Japan Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Androgenetic Alopecia Treatment Market Share by Country (2021-2032) Figure 57. Brazil Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Androgenetic Alopecia Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Agents
  • 5 AR Inhibitors
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Sun Pharmaceuticals Industries Ltd
  • Merck & Co., Inc
  • Vita-Cos-Med Klett-Loch GmbH
  • Vitabiotics
  • Ranbaxy Laboratories Ltd.
  • PureTech
  • Lexington International LLC
  • Johnson and Johnson Services, Inc
  • Histogen Inc
  • HCell Inc
  • Follica, Inc
  • Dr. Reddy’s Laboratories
  • Daiichi-Sankyo Co., Ltd
  • Concert Pharmaceuticals Inc.
  • Cipla Limited
  • Aclaris Therapeutics, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Androgenetic Alopecia Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Topical Agents
  5. 1.2.3 5 AR Inhibitors
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Androgenetic Alopecia Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Retail Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Hospital Pharmacies
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Androgenetic Alopecia Treatment Growth Trends by Region
  14. 1.5.1 Global Androgenetic Alopecia Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Androgenetic Alopecia Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Androgenetic Alopecia Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Androgenetic Alopecia Treatment Market Dynamics
  1. 2.1 Androgenetic Alopecia Treatment Industry Trends
  2. 2.2 Androgenetic Alopecia Treatment Industry Drivers
  3. 2.3 Androgenetic Alopecia Treatment Industry Opportunities and Challenges
  4. 2.4 Androgenetic Alopecia Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Androgenetic Alopecia Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Androgenetic Alopecia Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Androgenetic Alopecia Treatment Key Company Head office and Area Served
  4. 3.4 Global Androgenetic Alopecia Treatment Company, Product Type & Application
  5. 3.5 Global Androgenetic Alopecia Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Androgenetic Alopecia Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Androgenetic Alopecia Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Androgenetic Alopecia Treatment Tier 1, Tier 2, and Tier 3
4 Androgenetic Alopecia Treatment Market by Type
  1. 4.1 Global Androgenetic Alopecia Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Androgenetic Alopecia Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Androgenetic Alopecia Treatment Market Size Share by Type (2021-2032)
5 Androgenetic Alopecia Treatment Market by Application
  1. 5.1 Global Androgenetic Alopecia Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Androgenetic Alopecia Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Androgenetic Alopecia Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sun Pharmaceuticals Industries Ltd
  2. 6.1.1 Sun Pharmaceuticals Industries Ltd Company Information
  3. 6.1.2 Sun Pharmaceuticals Industries Ltd Business Overview
  4. 6.1.3 Sun Pharmaceuticals Industries Ltd Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sun Pharmaceuticals Industries Ltd Androgenetic Alopecia Treatment Product Portfolio
  6. 6.1.5 Sun Pharmaceuticals Industries Ltd Recent Developments
  7. 6.2 Merck & Co., Inc
  8. 6.2.1 Merck & Co., Inc Company Information
  9. 6.2.2 Merck & Co., Inc Business Overview
  10. 6.2.3 Merck & Co., Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck & Co., Inc Androgenetic Alopecia Treatment Product Portfolio
  12. 6.2.5 Merck & Co., Inc Recent Developments
  13. 6.3 Vita-Cos-Med Klett-Loch GmbH
  14. 6.3.1 Vita-Cos-Med Klett-Loch GmbH Company Information
  15. 6.3.2 Vita-Cos-Med Klett-Loch GmbH Business Overview
  16. 6.3.3 Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Vita-Cos-Med Klett-Loch GmbH Androgenetic Alopecia Treatment Product Portfolio
  18. 6.3.5 Vita-Cos-Med Klett-Loch GmbH Recent Developments
  19. 6.4 Vitabiotics
  20. 6.4.1 Vitabiotics Company Information
  21. 6.4.2 Vitabiotics Business Overview
  22. 6.4.3 Vitabiotics Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Vitabiotics Androgenetic Alopecia Treatment Product Portfolio
  24. 6.4.5 Vitabiotics Recent Developments
  25. 6.5 Ranbaxy Laboratories Ltd.
  26. 6.5.1 Ranbaxy Laboratories Ltd. Company Information
  27. 6.5.2 Ranbaxy Laboratories Ltd. Business Overview
  28. 6.5.3 Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Ranbaxy Laboratories Ltd. Androgenetic Alopecia Treatment Product Portfolio
  30. 6.5.5 Ranbaxy Laboratories Ltd. Recent Developments
  31. 6.6 PureTech
  32. 6.6.1 PureTech Company Information
  33. 6.6.2 PureTech Business Overview
  34. 6.6.3 PureTech Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 PureTech Androgenetic Alopecia Treatment Product Portfolio
  36. 6.6.5 PureTech Recent Developments
  37. 6.7 Lexington International LLC
  38. 6.7.1 Lexington International LLC Company Information
  39. 6.7.2 Lexington International LLC Business Overview
  40. 6.7.3 Lexington International LLC Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lexington International LLC Androgenetic Alopecia Treatment Product Portfolio
  42. 6.7.5 Lexington International LLC Recent Developments
  43. 6.8 Johnson and Johnson Services, Inc
  44. 6.8.1 Johnson and Johnson Services, Inc Company Information
  45. 6.8.2 Johnson and Johnson Services, Inc Business Overview
  46. 6.8.3 Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Johnson and Johnson Services, Inc Androgenetic Alopecia Treatment Product Portfolio
  48. 6.8.5 Johnson and Johnson Services, Inc Recent Developments
  49. 6.9 Histogen Inc
  50. 6.9.1 Histogen Inc Company Information
  51. 6.9.2 Histogen Inc Business Overview
  52. 6.9.3 Histogen Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Histogen Inc Androgenetic Alopecia Treatment Product Portfolio
  54. 6.9.5 Histogen Inc Recent Developments
  55. 6.10 HCell Inc
  56. 6.10.1 HCell Inc Company Information
  57. 6.10.2 HCell Inc Business Overview
  58. 6.10.3 HCell Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 HCell Inc Androgenetic Alopecia Treatment Product Portfolio
  60. 6.10.5 HCell Inc Recent Developments
  61. 6.11 Follica, Inc
  62. 6.11.1 Follica, Inc Company Information
  63. 6.11.2 Follica, Inc Business Overview
  64. 6.11.3 Follica, Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Follica, Inc Androgenetic Alopecia Treatment Product Portfolio
  66. 6.11.5 Follica, Inc Recent Developments
  67. 6.12 Dr. Reddy’s Laboratories
  68. 6.12.1 Dr. Reddy’s Laboratories Company Information
  69. 6.12.2 Dr. Reddy’s Laboratories Business Overview
  70. 6.12.3 Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Dr. Reddy’s Laboratories Androgenetic Alopecia Treatment Product Portfolio
  72. 6.12.5 Dr. Reddy’s Laboratories Recent Developments
  73. 6.13 Daiichi-Sankyo Co., Ltd
  74. 6.13.1 Daiichi-Sankyo Co., Ltd Company Information
  75. 6.13.2 Daiichi-Sankyo Co., Ltd Business Overview
  76. 6.13.3 Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Daiichi-Sankyo Co., Ltd Androgenetic Alopecia Treatment Product Portfolio
  78. 6.13.5 Daiichi-Sankyo Co., Ltd Recent Developments
  79. 6.14 Concert Pharmaceuticals Inc.
  80. 6.14.1 Concert Pharmaceuticals Inc. Company Information
  81. 6.14.2 Concert Pharmaceuticals Inc. Business Overview
  82. 6.14.3 Concert Pharmaceuticals Inc. Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Concert Pharmaceuticals Inc. Androgenetic Alopecia Treatment Product Portfolio
  84. 6.14.5 Concert Pharmaceuticals Inc. Recent Developments
  85. 6.15 Cipla Limited
  86. 6.15.1 Cipla Limited Company Information
  87. 6.15.2 Cipla Limited Business Overview
  88. 6.15.3 Cipla Limited Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Cipla Limited Androgenetic Alopecia Treatment Product Portfolio
  90. 6.15.5 Cipla Limited Recent Developments
  91. 6.16 Aclaris Therapeutics, Inc
  92. 6.16.1 Aclaris Therapeutics, Inc Company Information
  93. 6.16.2 Aclaris Therapeutics, Inc Business Overview
  94. 6.16.3 Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Aclaris Therapeutics, Inc Androgenetic Alopecia Treatment Product Portfolio
  96. 6.16.5 Aclaris Therapeutics, Inc Recent Developments
7 North America
  1. 7.1 North America Androgenetic Alopecia Treatment Market Size (2021-2032)
  2. 7.2 North America Androgenetic Alopecia Treatment Market Size by Type
  3. 7.2.1 North America Androgenetic Alopecia Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Androgenetic Alopecia Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Androgenetic Alopecia Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Androgenetic Alopecia Treatment Market Size by Application
  7. 7.3.1 North America Androgenetic Alopecia Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Androgenetic Alopecia Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Androgenetic Alopecia Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Androgenetic Alopecia Treatment Market Size by Country
  11. 7.4.1 North America Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Androgenetic Alopecia Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Androgenetic Alopecia Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Androgenetic Alopecia Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Androgenetic Alopecia Treatment Market Size (2021-2032)
  2. 8.2 Europe Androgenetic Alopecia Treatment Market Size by Type
  3. 8.2.1 Europe Androgenetic Alopecia Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Androgenetic Alopecia Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Androgenetic Alopecia Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Androgenetic Alopecia Treatment Market Size by Application
  7. 8.3.1 Europe Androgenetic Alopecia Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Androgenetic Alopecia Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Androgenetic Alopecia Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Androgenetic Alopecia Treatment Market Size by Country
  11. 8.4.1 Europe Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Androgenetic Alopecia Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Androgenetic Alopecia Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Androgenetic Alopecia Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Androgenetic Alopecia Treatment Market Size (2021-2032)
  2. 9.2 China Androgenetic Alopecia Treatment Market Size by Type
  3. 9.2.1 China Androgenetic Alopecia Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Androgenetic Alopecia Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Androgenetic Alopecia Treatment Market Share by Type (2021-2032)
  6. 9.3 China Androgenetic Alopecia Treatment Market Size by Application
  7. 9.3.1 China Androgenetic Alopecia Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Androgenetic Alopecia Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Androgenetic Alopecia Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Androgenetic Alopecia Treatment Market Size (2021-2032)
  2. 10.2 Asia Androgenetic Alopecia Treatment Market Size by Type
  3. 10.2.1 Asia Androgenetic Alopecia Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Androgenetic Alopecia Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Androgenetic Alopecia Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Androgenetic Alopecia Treatment Market Size by Application
  7. 10.3.1 Asia Androgenetic Alopecia Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Androgenetic Alopecia Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Androgenetic Alopecia Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Androgenetic Alopecia Treatment Market Size by Country
  11. 10.4.1 Asia Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Androgenetic Alopecia Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Androgenetic Alopecia Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Androgenetic Alopecia Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Androgenetic Alopecia Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research